Cargando…
A randomised double-blind placebo-controlled 12- week feasibility trial of methotrexate added to treatment as usual in early schizophrenia: study protocol for a randomised controlled trial
BACKGROUND: Methotrexate is a commonly used anti-inflammatory and immunosuppressive drug. There is growing evidence that inflammatory processes are involved in the pathogenesis of schizophrenia. In our recent randomised double-blind placebo-controlled clinical trial in Pakistan and Brazil, the addit...
Autores principales: | Chaudhry, Imran B, Husain, Nusrat, ur Rahman, Raza, Husain, Mohammed Omair, Hamirani, Mohammed M, Kazmi, Ajmal, Baig, Shakeel, Haddad, Peter M, Buch, Maya H, Qureshi, Inti, Mehmood, Nasir, Kiran, Tayyeba, Fu, Bo, Afsar, Salahuddin, Deakin, Bill |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326487/ https://www.ncbi.nlm.nih.gov/pubmed/25563714 http://dx.doi.org/10.1186/1745-6215-16-9 |
Ejemplares similares
-
Pilot randomised controlled trial of culturally adapted cognitive behavior therapy for psychosis (CaCBTp) in Pakistan
por: Husain, Muhammed Omair, et al.
Publicado: (2017) -
Ondansetron and simvastatin added to treatment as usual in patients with schizophrenia: study protocol for a randomized controlled trial
por: Chaudhry, Imran B, et al.
Publicado: (2013) -
Minocycline as an adjunct for treatment-resistant depressive symptoms: study protocol for a pilot randomised controlled trial
por: Husain, Muhammad I., et al.
Publicado: (2015) -
Adjunctive simvastatin for treatment-resistant depression: study protocol of a 12-week randomised controlled trial
por: Husain, Muhammad I., et al.
Publicado: (2019) -
A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol
por: Qurashi, Inti, et al.
Publicado: (2017)